معرفی
Thomas Lecompte serves as a Professor at the University of Namur's School of Medicine within the Department of Medical Laboratory Sciences. With an exceptional h-index of 189 and 22 research outputs spanning 2020-2025, he maintains an active research profile in hematology and laboratory medicine. His work demonstrates consistent productivity with 6 publications in 2025 alone.
Dr. Lecompte's research focuses on critical hemostasis and thrombosis mechanisms, specializing in platelet function, coagulation testing, and anticoagulant therapy. His fingerprint analysis reveals dominant expertise in Platelet Medicine (73%), in vitro modeling (60%), and laboratories (60%), with significant contributions to heparin therapy, plasma analysis, and diagnostic protocols. Recent work emphasizes preanalytical variables in coagulation testing and standardization of laboratory methods.
His publication trends show increasing output from 1 article in 2020 to 8 in 2023, with 2024-2025 maintaining high productivity through both original research and review articles. Key themes include diagnostic reliability under inflammatory conditions, catheter-related thrombin generation, and δ-granule defect diagnostics. Recent collaborations include Hardy, Mullier, and Douxfils across multiple high-impact hematology journals.
While no specific awards are listed in the provided data, his work has been referenced in clinical guidelines and cited extensively (1-2 citations per recent article). His research has garnered attention from 5 Mendeley readers and clinical guideline sources, demonstrating practical clinical impact.
Dr. Lecompte contributes significantly to laboratory hematology standardization through detailed protocol development. His current work focuses on improving diagnostic accuracy in coagulation testing, particularly regarding preanalytical variables, lupus anticoagulant reliability during inflammation, and platelet defect diagnostics. Ongoing projects likely involve catheter-thrombosis modeling and heparin management protocols.
